Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Big Tex House of Coin -- Ignore unavailable to you. Want to Upgrade?

To: Spark who wrote (7291)	9/21/1999 1:11:00 PM
From: Spark	Respond to of 19297

September 21, 1999 09:30 Sepragen Corporation Announces Successful Commissioning of Sepralac Plant at Carbery Food Ingredients HAYWARD, Calif.--(BW HealthWire)--Sept. 21, 1999--Sepragen Corporation (OTC BB: SPGNA, SPGNU, SPGNW) announced the successful start of the first plant in Europe based on its patented Sepralac(R) Process. The plant was commissioned by Carbery Food Ingredients, of Ireland, pursuant to a license agreement reached between Sepragen and Carbery. Carbery's plant will produce, amongst other ingredients, alpha-lactalbumin and lactoferrin which are high value ingredients extracted from cheese whey. These ingredients are being targeted for producing next generation infant formulae that more closely resemble the protein profile of human breast milk, and as health enhancing additives in 'nutraceutical' or dietary supplement products. Carbery will also utilize some innovative whey fractions to enhance its existing Isolac range of sportsfood ingredients. Said John Holland, Operations Director for Carbery, "Carbery Food Ingredients is a technology leader in the manufacture of whey based ingredients and is a well recognized supplier to leading infant formulae producers. The manufacture of this new generation of ingredients will enable us to continue operating a the frontiers of whey technology and give us the ability to better serve our customers with exciting technical innovations. We expect our relationship with Sepragen to grow as we position ourselves as a global supplier of high-end ingredients to both existing and new customers." Sepragen Corporation develops and markets technology along with equipment and supplies for process chromatography applications. Sepragen has developed a number of patented applications that provide large market opportunities in the food and beverage industry, including debittering citrus juices, extracting isoflavone (plant estrogen) from soy, as well as extracting proteins from whey. The Company holds over 14 issued patents relating to its core technology. The statements in this release that relate to future events or performance of Sepragen Corporation, statements about its growth, market acceptance, levels of sales and market size, and future manufacturing capacity and efficiencies are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to the development of markets for and commercial acceptance of Sepragen's products and services, the availability of components, competitors' product introductions and other risks identified in its SEC filings. Actual results may differ from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. CONTACT: Sepragen Corporation, Hayward Vinit Saxena, 510/476-0650 (CEO) or Aimee Boutcher, 973/239-2878 (IR) SEPRAGEN CORP CL A - SPGNA Price 0.718 Net Change 0 Volume (000) 0 Day High 0 Day Low 0 SEPRAGEN CORP UTS 2000 - SPGNU Price 0.593 Net Change 0 Volume (000) 0 Day High 0 Day Low 0 SEPRAGEN CORP WTS A 2000 - SPGNW Price 0.01 Net Change 0 Volume (000) 0 Day High 0 Day Low 0 as of 09/21/99 13:08 PM EDT